CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 124 filers reported holding CYTOKINETICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,813,080 | +51.3% | 51,921 | +95.8% | 0.10% | +44.4% |
| Q1 2024 | $1,859,387 | -53.4% | 26,521 | -44.5% | 0.07% | -57.9% |
| Q4 2023 | $3,986,564 | +195.0% | 47,749 | +4.1% | 0.17% | +128.0% |
| Q3 2023 | $1,351,595 | -8.8% | 45,879 | +1.0% | 0.08% | -6.2% |
| Q2 2023 | $1,481,992 | +5.1% | 45,432 | +13.4% | 0.08% | -8.0% |
| Q1 2023 | $1,410,204 | +442.9% | 40,074 | +606.9% | 0.09% | +411.8% |
| Q4 2022 | $259,754 | -14.0% | 5,669 | -9.2% | 0.02% | -22.7% |
| Q3 2022 | $302,000 | +33.0% | 6,243 | +8.3% | 0.02% | +57.1% |
| Q2 2022 | $227,000 | -9.9% | 5,766 | -15.9% | 0.01% | +27.3% |
| Q1 2022 | $252,000 | -27.0% | 6,855 | -9.5% | 0.01% | 0.0% |
| Q4 2021 | $345,000 | +21.5% | 7,571 | -4.9% | 0.01% | +10.0% |
| Q3 2021 | $284,000 | +186.9% | 7,958 | -20.7% | 0.01% | +150.0% |
| Q3 2018 | $99,000 | +8.8% | 10,029 | -8.8% | 0.00% | 0.0% |
| Q2 2018 | $91,000 | – | 10,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,721,888 | $46,633,000 | 5.62% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 107,139 | $873,000 | 0.62% |
| Virtus ETF Advisers LLC | 42,645 | $348,000 | 0.44% |
| SPHERA FUNDS MANAGEMENT LTD. | 210,000 | $1,712,000 | 0.20% |
| LANSDOWNE PARTNERS (UK) LLP | 2,647,981 | $21,581,000 | 0.20% |
| WASATCH ADVISORS LP | 1,679,778 | $13,690,000 | 0.18% |
| PINNACLE ASSOCIATES LTD | 877,575 | $7,152,000 | 0.14% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 107,728 | $878,000 | 0.12% |
| Tekla Capital Management LLC | 350,300 | $2,855,000 | 0.11% |
| Financial Gravity Companies, Inc. | 9,302 | $86,000 | 0.10% |